Viewing Study NCT05751850


Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2025-12-27 @ 2:26 PM
Study NCT ID: NCT05751850
Status: RECRUITING
Last Update Posted: 2024-05-09
First Post: 2023-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Cancer
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module